Hence, DPP-IV inhibitors are nowadays considered as an advanced class of agents for T2DM management [16] and in recent years, numerous studies evidenced “natural” DPP-IV inhibitory peptides from digested dietary proteins [17]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.